Ellis Investment Partners, LLC - NOVAVAX INC ownership

NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 255 filers reported holding NOVAVAX INC in Q3 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.0%.

Quarter-by-quarter ownership
Ellis Investment Partners, LLC ownership history of NOVAVAX INC
ValueSharesWeighting
Q3 2022$2,000
-71.4%
1500.0%0.00%
-50.0%
Q2 2022$7,000
-36.4%
1500.0%0.00%
-33.3%
Q1 2022$11,000
-47.6%
1500.0%0.00%
-40.0%
Q4 2021$21,000
+5.0%
150
+50.0%
0.01%0.0%
Q3 2021$20,000
-4.8%
1000.0%0.01%0.0%
Q2 2021$21,000
+16.7%
1000.0%0.01%0.0%
Q1 2021$18,000
+63.6%
1000.0%0.01%
+66.7%
Q4 2020$11,0001000.00%
Other shareholders
NOVAVAX INC shareholders Q3 2022
NameSharesValueWeighting ↓
RA Capital Management 3,002,087$544,308,0008.21%
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 323,517$58,657,0007.86%
Samsara BioCapital, LLC 198,600$36,008,0006.64%
Foresite Capital Management I, LLC 66,810$12,113,0006.11%
Foresite Capital Management II, LLC 67,373$12,215,0002.81%
SECTORAL ASSET MANAGEMENT INC 191,200$34,666,0002.63%
Rock Springs Capital Management LP 461,000$83,584,0001.82%
TSP Capital Management Group, LLC 23,525$4,265,0001.50%
Ikarian Capital, LLC 195,700$35,483,0001.19%
SevenOneSeven Capital Management 1,744$316,0001.16%
View complete list of NOVAVAX INC shareholders